Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen

被引：15

作者：

Washizaki, Ayaka ^{[1
]}

Murayama, Asako ^{[2
]}

Murata, Megumi ^{[1
]}

Kiyohara, Tomoko ^{[2
]}

Yato, Keigo ^{[2
]}

Yamada, Norie ^{[2
]}

Aly, Hussein Hassan ^{[2
]}

Tanaka, Tomohisa ^{[3
]}

Moriishi, Kohji ^{[3
,4
]}

Nishitsuji, Hironori ^{[5
]}

Shimotohno, Kunitada ^{[6
]}

Goh, Yasumasa ^{[7
]}

Ishii, Ken J. ^{[8
]}

Yotsuyanagi, Hiroshi ^{[9
]}

Muramatsu, Masamichi ^{[2
]}

Ishii, Koji ^{[10
]}

Takahashi, Yoshimasa ^{[11
]}

Suzuki, Ryosuke ^{[2
]}

Akari, Hirofumi ^{[1
]}

Kato, Takanobu ^{[2
]}

机构：

[1] Kyoto Univ, Ctr Evolutionary Origins Human Behav, Inuyama, Aichi, Japan

[2] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan

[3] Univ Yamanashi, Grad Sch Med, Dept Microbiol, Kofu, Yamanashi, Japan

[4] Hokkaido Univ, Inst Genet Med, Div Hepatitis Virol, Sapporo, Hokkaido, Japan

[5] Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi, Japan

[6] Natl Ctr Global Hlth & Med, Genome Med Sci Project, Chiba, Japan

[7] Beacle Inc, Res Lab, Kyoto, Japan

[8] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Vaccine Sci, Tokyo, Japan

[9] Univ Tokyo, Adv Clin Res Ctr, Inst Med Sci, Div Infect Dis, Tokyo, Japan

[10] Natl Inst Infect Dis, Dept Qual Assurance Radiat Safety & Informat Syst, Tokyo, Japan

[11] Natl Inst Infect Dis, Res Ctr Drug & Vaccine Dev, Tokyo, Japan

来源：

NATURE COMMUNICATIONS | 2022年 / 13卷 / 01期

关键词：

SURFACE-ANTIGEN; UNIVERSAL VACCINATION; IMPLEMENTATION; PURIFICATION; PARTICLES; MUTANT; GENE;

D O I：

10.1038/s41467-022-32910-z

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Although the current hepatitis B (HB) vaccine comprising small-HBs antigen (Ag) is potent and safe, attenuated prophylaxis against hepatitis B virus (HBV) with vaccine-escape mutations (VEMs) has been reported. We investigate an HB vaccine consisting of large-HBsAg that overcomes the shortcomings of the current HB vaccine. Yeast-derived large-HBsAg is immunized into rhesus macaques, and the neutralizing activities of the induced antibodies are compared with those of the current HB vaccine. Although the antibodies induced by the current HB vaccine cannot prevent HBV infection with VEMs, the large-HBsAg vaccine-induced antibodies neutralize those infections. The HBV genotypes that exhibited attenuated neutralization via these vaccines are different. Here, we show that the HB vaccine consisting of large-HBsAg is useful to compensate for the shortcomings of the current HB vaccine. The combined use of these HB vaccines may induce antibodies that can neutralize HBV strains with VEMs or multiple HBV genotypes.

引用

页数：12

共 50 条

[1] Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen
Ayaka Washizaki
Asako Murayama
Megumi Murata
Tomoko Kiyohara
Keigo Yato
Norie Yamada
Hussein Hassan Aly
Tomohisa Tanaka
Kohji Moriishi
Hironori Nishitsuji
Kunitada Shimotohno
Yasumasa Goh
Ken J. Ishii
Hiroshi Yotsuyanagi
Masamichi Muramatsu
Koji Ishii
Yoshimasa Takahashi
Ryosuke Suzuki
Hirofumi Akari
Takanobu Kato
Nature Communications, 13
[2] Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen
Cooreman, MP
Leroux-Roels, G
Paulij, WP
JOURNAL OF BIOMEDICAL SCIENCE, 2001, 8 (03) : 237 - 247
[3] Antiviral drug-associated potential vaccine-escape hepatitis B virus mutants in Turkish patients with chronic hepatitis B
Sayan, M.
Akhan, S. C.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 (10) : E722 - E726
[4] Antiviral drug-associated potential vaccine-escape hepatitis B virus mutants in Turkish patients with chronic hepatitis B
Sayan, M.
Akhan, S. C.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E109 - E109
[5] Detection of hepatitis B virus surface antigen in hepatitis B vaccine recipients
Chawla, YK
Sharma, SK
Saini, N
Arora, L
Masih, B
Duseja, A
Dhiman, RK
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S104 - S105
[6] High Incidence of Treatment-Induced and Vaccine-Escape Hepatitis B Virus Mutants Among Human Immunodeficiency Virus/Hepatitis B-Infected Patients
Lacombe, Karine
Boyd, Anders
Lavocat, Fabien
Pichoud, Christian
Gozlan, Joel
Miailhes, Patrick
Lascoux-Combe, Caroline
Vernet, Guy
Girard, Pierre-Marie
Zoulim, Fabien
HEPATOLOGY, 2013, 58 (03) : 912 - 922
[7] De novo hepatitis B due to vaccine-escape mutants in a liver transplant recipient
Molina Rueda, Maria Jose
Jimenez Romano, Elena
Fernandez Sierra, Maria Amelia
GASTROENTEROLOGIA Y HEPATOLOGIA, 2013, 36 (08): : 546 - 547
[8] RESEARCH AND THE DEVELOPMENT OF A VACCINE FOR THE HEPATITIS-B VIRUS - INCLUDING HEPATITIS-B ANTIGEN POLYPEPTIDE VACCINE
AKAHANE, Y
JAPANESE JOURNAL OF CLINICAL MEDICINE, 1981, 39 (03): : 145 - 156
[9] The distribution of hepatitis B virus surface antigen polymorphisms at positions associated with vaccine escape
Raheel, Mahad
Choga, Wonderful T.
Blackard, Jason T.
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (12) : 3336 - 3343
[10] Therapeutic effect of preS2-containing vaccine in an infant infected with a vaccine-escape variant (Thr(127)) of hepatitis B virus
Noto, H
Fujii, Y
Takahashi, K
Kishimoto, S
Mishiro, S
INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 1997, 6 (3-4): : 158 - 165

← 1 2 3 4 5 →